Search

Experts in oncology, immunotherapy and oncolytic viruses to help guide KaliVir's development of systemically deliverable oncolytic virus immunotherapies PITTSBURGH, Dec. 13, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3734963-1&h=1649061412&u=https%3A%2F%2Fkalivir.com%2F&a=KaliVir+Immunotherapeutics%2C+Inc., a biotech company developing cutting-edge, [...]

PITTSBURGH, July 29, 2022 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=3606818-1&h=4149629973&u=https%3A%2F%2Fnovasenta.com%2F&a=Novasenta+Inc., a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies, today announced the completion of $40 [...]

PITTSBURGH, Aug. 24, 2021 /PRNewswire/ -- As part of its commitment to investing in translational science that significantly improves the lives of patients, UPMC has launched Novasenta, a drug discovery [...]

St. Jude Children's Research Hospital researchers discover how to unleash the immune system against cancer in mice without triggering autoimmune reactions MEMPHIS, Tenn., August 4, 2013 /PRNewswire-USNewswire/ -- St. Jude [...]